Leukemia Edition: Top Headlines for Week of July 31, 2023
- Author
- Healio
- Published
- Thu 03 Aug 2023
- Episode Link
- http://sites.libsyn.com/408806/leukemia-edition-top-headlines-for-week-of-july-31-2023
In this edition, FDA approves Vanflyta for newly diagnosed AML; liso-cel could have ‘best shot’ at remission for double refractory CLL; mortality factors among cancer survivors and more. Read the full coverage here:
FDA approves Vanflyta for newly diagnosed acute myeloid leukemia
VIDEO: Liso-cel could have ‘best shot’ at remission for double refractory CLL
Community affluence, insurance mediate CV mortality among Black, white cancer survivors
VIDEO: MOLTO study probes combination therapy in Richter syndrome
Gilead terminates phase 3 trial of magrolimab regimen for myelodysplastic syndrome
References:
ASCO Annual Meeting ASCO Annual Meeting Press Release Press Release Sung H, et al. Int J Epidemiol. 2023;doi:10.1093/ije/dyad097.
